Rockefeller Capital Management
PASG icon

Rockefeller Capital Management’s Passage Bio PASG Stock Holding History

Rockefeller Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-800
Closed -$6.28K – 4839
2026
Q1 		$6.28K Buy
800
+300
+60% +$3.1K ﹤0.01% 4178
2025
Q4 		$5.9K Buy
+500
New +$4.32K ﹤0.01% 4016
2021
Q2 		– Sell
-379
Closed -$132K – 3561
2021
Q1 		$132K Sell
379
-8
-2% -$3.42K ﹤0.01% 1493
2020
Q4 		$197K Hold
387
– – ﹤0.01% 1197
2020
Q3 		$101K Buy
387
+161
+71% +$55.4K ﹤0.01% 1250
2020
Q2 		$124K Buy
+226
New +$102K ﹤0.01% 1094

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Rockefeller Capital Management's PASG Position: Q2 2026 in Review

Rockefeller Capital Management sold out of Passage Bio (PASG) in Q2 2026, closing a stake of 800 shares — an estimated $6.28K sold.

Rockefeller Capital Management first reported a position in PASG in Q2 2020 and held it in 6 quarters. The position peaked at $197K in Q4 2020. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Rockefeller Capital Management reported no remaining Passage Bio position as of Q2 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 800 Passage Bio shares in Q2 2026, an estimated $6.28K.
  • Rockefeller Capital Management first reported a position in Passage Bio in Q2 2020 and held it in 6 quarters.
  • Rockefeller Capital Management's Passage Bio position peaked at $197K in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.